NeuroOne Medical Technologies Corporation
NCM: NMTCLive Quote
About NeuroOne Medical Technologies Corporation
Healthcare
Medical Devices
NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders. The company is based in Eden Prairie, Minnesota.
📊 Fundamental Analysis
NeuroOne Medical Technologies Corporation demonstrates a profit margin of -58.3%, which is below the sector average, suggesting competitive pressure.
The company recently reported -11.7% revenue growth, which is negative, indicating a recent decline in revenue.
Return on Equity (ROE) is -146.3%, which indicates that capital utilization is currently under pressure.
At a current price of $0.73, NMTC currently sits at the 37th percentile of its 52-week range (Range: $0.47 - $1.16).
🏥 Financial Health
🔴
Profit Margin
Weak
🔴
Debt/Equity
Elevated
🔴
Revenue Growth
Weak
🔴
Return on Equity
Weak
✅
Beta (Risk)
Low Volatility
Key Financials
Market Cap
$29.22M
Trailing P/E
--
Forward P/E
-2.61
Beta (5Y)
0.58
52W High
$1.16
52W Low
$0.47
Avg Volume
209K
Day High
Day Low
📡 Subscribe to ZcoreAI updates
Join the list to get access to:
- Z-Score signals at market open
- New app features and updates
- Exclusive promo for ZcoreAI App